Willem W. Overwijk PhD

Willem Overwijk, Ph.D. received his MS in Medical Biology from Utrecht University in the Netherlands, trained at the Surgery Branch, National Cancer Institute in Bethesda, MD, and received his Ph.D. in Biochemistry and Molecular Biology from the George Washington University in Washington, DC. He completed his postgraduate training at the Netherlands Cancer Institute in Amsterdam before accepting a faculty position at MD Anderson Cancer Center where he focused on translational research in Immuno-Oncology. In 2018 he joined Nektar Therapeutics in San Francisco as vice president of oncology research to continue working on bringing novel agents in Immuno-Oncology to patients.